Creative Medical Technology Holdings, Inc. (CELZ) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 698.60K USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 125.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $698.60K | (m) | (m) | (m) | $125.00K | (m) |
| 2026-03-31 | (m) | $307.65K | (m) | (m) | (m) | $125.00K | (m) |
| 2025-12-31 | (m) | $284.88K | (m) | (m) | (m) | $0.00 | (m) |
| 2025-09-30 | (m) | $261.35K | (m) | (m) | (m) | $994.00 | (m) |
| 2025-06-30 | (m) | $277.64K | (m) | (m) | (m) | $994.00 | (m) |
| 2025-03-31 | (m) | $286.39K | (m) | (m) | (m) | $994.00 | (m) |
| 2024-12-31 | (m) | $327.64K | (m) | (m) | (m) | $2.19K | (m) |
| 2024-09-30 | (m) | $330.91K | (m) | (m) | (m) | $3.39K | (m) |
| 2024-06-30 | (m) | $376.27K | (m) | (m) | (m) | $3.39K | (m) |
| 2024-03-31 | (m) | $390.96K | (m) | (m) | (m) | $6.59K | (m) |
| 2023-12-31 | (m) | $371.39K | (m) | (m) | (m) | $6.59K | (m) |
| 2023-09-30 | (m) | $421.16K | $4.51M | (m) | (m) | $7.79K | (m) |
| 2023-06-30 | (m) | $398.53K | $3.99M | (m) | (m) | $10.19K | (m) |
| 2023-03-31 | (m) | $407.54K | (m) | (m) | (m) | $10.19K | (m) |
| 2022-12-31 | (m) | $3.32M | (m) | (m) | $0.00 | $10.19K | (m) |
| 2022-09-30 | (m) | $396.96K | (m) | (m) | $0.00 | $15.89K | (m) |
| 2022-06-30 | (m) | $389.80K | $22.86M | (m) | (m) | $20.63K | (m) |
| 2022-03-31 | (m) | $379.80K | $9.15M | (m) | (m) | $14.15K | (m) |
| 2021-12-31 | (m) | $1.05M | $10.72M | (m) | (m) | $10.87K | (m) |
| 2021-09-30 | (m) | $3.50M | $2.38M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.45M | $158.59K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $3.31M | $275.13K | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $40.52M | $98.01K | (m) | $0.00 | (m) | (m) |
| 2020-09-30 | (m) | $3.20M | $38.71K | (m) | $0.00 | $0.00 | (m) |
| 2020-06-30 | (m) | $4.65M | $37.02K | (m) | $1.40K | $1.20K | (m) |
| 2020-03-31 | (m) | $3.65M | (m) | (m) | $8.40K | $2.80K | (m) |
| 2019-12-31 | (m) | $8.60M | $88.65K | (m) | $5.60K | (m) | (m) |
| 2019-09-30 | (m) | $3.89M | (m) | (m) | $24.50K | (m) | (m) |
| 2019-06-30 | (m) | $3.00M | (m) | (m) | $1.00K | (m) | (m) |
| 2019-03-31 | (m) | $4.18M | $419.48K | (m) | $163.00 | (m) | (m) |
| 2018-12-31 | (m) | $4.47M | $304.06K | (m) | $9.60K | (m) | (m) |
| 2018-09-30 | (m) | $7.71M | $172.83K | (m) | $14.00K | (m) | (m) |
| 2018-06-30 | (m) | $10.87M | $100.50K | (m) | $4.80K | (m) | (m) |
| 2018-03-31 | (m) | $8.22M | $102.31K | (m) | $9.60K | (m) | (m) |
| 2017-12-31 | (m) | $2.44M | $13.70K | (m) | $4.80K | (m) | (m) |
| 2017-09-30 | (m) | $1.27M | $21.22K | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.31M | $104.40K | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $468.87K | $98.12K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $453.86K | $221.87K | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $445.96K | $33.46K | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $304.02K | $25.76K | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $216.00 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $157.82K | $216.00 | (m) | (m) | (m) | (m) |
| 2015-12-29 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $741.00 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $641.00 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $162.90K | $583.00 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $154.00K | $954.00 | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $147.83K | $1.29K | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $142.08K | $1.29K | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $136.34K | $1.29K | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $125.41K | $374.00 | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $119.38K | $398.00 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $113.94K | $403.00 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $109.58K | $597.00 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $99.32K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-03 | (m) | (m) | $781.00 | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $92.91K | $756.00 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $86.78K | $531.00 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $82.85K | $631.00 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $75.27K | $1.10K | (m) | (m) | (m) | (m) |
| 2011-12-03 | (m) | (m) | $1.10K | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $69.57K | $1.21K | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $61.16K | $400.00 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $314.00 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $48.52K | $414.00 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $253.00 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $104.00 | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $575.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |